BIOMAT Database Logo BIOMAT Database Logo

[Dexamethasone test in endogenous depression]. 1984

E Taracha, and M Beresewicz, and E Bidzińska, and A Kalinowski, and B Szukalski, and S Puzyński, and M Załuska

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010912 Pituitary-Adrenal Function Tests Tests that evaluate the adrenal glands controlled by pituitary hormones. Function Test, Pituitary-Adrenal,Function Tests, Pituitary-Adrenal,Pituitary Adrenal Function Tests,Pituitary-Adrenal Function Test,Test, Pituitary-Adrenal Function,Tests, Pituitary-Adrenal Function
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive

Related Publications

E Taracha, and M Beresewicz, and E Bidzińska, and A Kalinowski, and B Szukalski, and S Puzyński, and M Załuska
The dexamethasone supperssion test in endogenous depression.
October 1989, Indian journal of psychiatry,
E Taracha, and M Beresewicz, and E Bidzińska, and A Kalinowski, and B Szukalski, and S Puzyński, and M Załuska
Dexamethasone suppression test and TRH test in endogenous depression.
April 1983, Acta psychiatrica Scandinavica,
E Taracha, and M Beresewicz, and E Bidzińska, and A Kalinowski, and B Szukalski, and S Puzyński, and M Załuska
A modified dexamethasone suppression test for endogenous depression.
August 1985, Psychiatry research,
E Taracha, and M Beresewicz, and E Bidzińska, and A Kalinowski, and B Szukalski, and S Puzyński, and M Załuska
Plasma endogenous opioids and dexamethasone suppression test in depression.
June 1987, Psychiatry research,
E Taracha, and M Beresewicz, and E Bidzińska, and A Kalinowski, and B Szukalski, and S Puzyński, and M Załuska
Dexamethasone suppression test and sleep deprivation in endogenous depression.
September 1985, Journal of affective disorders,
E Taracha, and M Beresewicz, and E Bidzińska, and A Kalinowski, and B Szukalski, and S Puzyński, and M Załuska
[The dexamethasone suppression test in schizophrenia and endogenous depression].
January 1988, Psychiatria polska,
E Taracha, and M Beresewicz, and E Bidzińska, and A Kalinowski, and B Szukalski, and S Puzyński, and M Załuska
[Laboratory diagnosis of endogenous depression: the dexamethasone suppression test].
July 1982, Orvosi hetilap,
E Taracha, and M Beresewicz, and E Bidzińska, and A Kalinowski, and B Szukalski, and S Puzyński, and M Załuska
[Dexamethasone suppression test: a biologic marker of endogenous depression?].
January 1984, European archives of psychiatry and neurological sciences,
E Taracha, and M Beresewicz, and E Bidzińska, and A Kalinowski, and B Szukalski, and S Puzyński, and M Załuska
[Preliminary study of the dexamethasone suppression test in endogenous depression].
January 1983, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
E Taracha, and M Beresewicz, and E Bidzińska, and A Kalinowski, and B Szukalski, and S Puzyński, and M Załuska
Four definitions of endogenous depression and the dexamethasone suppression test.
January 1985, Journal of affective disorders,
Copied contents to your clipboard!